Acute Myeloid Leukemia: Reviewing Current Best Practice and Exploring Novel Paradigms Ahead

In this commentary, expert faculty address audience questions from a live symposium on current and emerging AML treatment strategies.

Daniel Pollyea, MD, MS
Program Director Courtney DiNardo, MD, MSCE Eytan M. Stein, MD Released: January 24, 2023

Download these slides from a live symposium for the most recent data on updated AML classifications and selecting AML therapy for patients without actionable alterations.

Courtney DiNardo, MD, MSCE Released: December 9, 2022

Download these slides from a live symposium for the most recent data on selecting AML therapy for patients with predictive biomarkers or actionable alterations.

Eytan M. Stein, MD Released: December 9, 2022

Download these slides from a live symposium for information on key clinical trials in AML as well as future directions.

Daniel Pollyea, MD, MS Released: December 9, 2022